1. What Is the Continuous Chromatography Market?
The Continuous Chromatography Market encompasses multi-column chromatography systems, simulated moving bed configurations, and periodic counter-current chromatography technologies. These achieve continuous or semi-continuous biomolecule purification by operating multiple columns in parallel at different stages of the bind-wash-elute cycle. The market includes multi-column continuous chromatography systems for monoclonal antibody capture and twin-column capture systems for continuous affinity purification. It also includes simulated moving bed polishing systems that enable continuous protein fractionation and aggregate removal beyond batch column cycles. These systems are used by biopharmaceutical manufacturers to increase resin utilisation, reduce column size requirements, and enable continuous flow connection between upstream bioreactors and downstream purification trains for end-to-end continuous manufacturing processes. Market scope covers multi-column continuous chromatography equipment, resins, and software configurations for biopharmaceutical downstream processing. It excludes single-column batch chromatography systems, continuous fluidised bed adsorption, and small molecule chemical continuous chromatography for food and chemical applications.
2. Continuous Chromatography Market Size & Forecast
3. Emerging Technologies
- Continuous manufacturing regulatory pathway development is advancing FDA and EMA guidance documents for ICH Q13 continuous manufacturing applications in biologics, providing biopharmaceutical manufacturers with clearer regulatory expectations for continuous chromatography process validation and control. Growing industry adoption of this technology is motivating development.
- In-line process analytical technology for continuous chromatography is advancing real-time UV, conductivity, and mass spectrometry in-line sensors that monitor continuous chromatography effluent stream quality between batches, enabling automated fraction collection and product pooling without. Growing industry adoption of this technology is motivating development.
- Disposable flow path continuous chromatography is advancing single-use tube and valve manifold configurations for continuous multi-column systems that eliminate cross-contamination risk between product campaigns and reduce cleaning validation requirements. Growing industry adoption of this technology is motivating development.
- AI-optimised continuous chromatography control systems are advancing machine learning models that predict optimal gradient timing, column switching points, and product pooling thresholds from real-time sensor data across multi-column continuous systems. Growing biopharmaceutical manufacturer interest.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Size Exclusion Chromatography Market.
4. Key Market Opportunity
One of the major opportunities in the Continuous Chromatography Market is the adoption of continuous Protein A capture at commercial monoclonal antibody manufacturing facilities as an upgrade to existing batch capture platforms to reduce resin consumption, column footprint, and manufacturing cost. A significant proportion of commercial monoclonal antibody manufacturing operations continue using batch single-column Protein A capture despite available continuous capture technology that demonstrates 30 to 50 percent resin consumption reduction and proportional column size reduction. Continuous Protein A capture retrofits at existing commercial facilities create immediate capital cost reduction from smaller column purchases and ongoing savings from reduced resin replacement frequency through improved dynamic binding capacity utilisation. Continuous chromatography system developers that demonstrate validated continuous capture retrofit capability for existing GMP infrastructure, quantify resin and capital cost savings with site-specific ROI models, and provide technology transfer and validation assistance are positioned to accelerate commercial facility adoption.
5. Top Companies in the Continuous Chromatography Market
The following organisations hold leading positions in the Continuous Chromatography Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Cytiva (BioSMB)
- Repligen
- Novatek International
- GEA Group
- ChromaCon
- Pall Life Sciences
- MCSGP Technology
- EMD Millipore (Merck)
- Semba Biosciences
- Asahi Kasei
6. Market Segmentation
The Continuous Chromatography Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | Multi-Column Continuous Capture BioSMB Multi-Column PCC Periodic Counter-Current Twin-Column Capture Twin-Column Capture Recycle Capture SMB Simulated Moving Bed Polishing SMB Polishing Step Continuous Ion Exchange Continuous IEX Polishing Integrated Continuous Bioprocessing ICB System |
| By Application | mAb Capture Continuous Protein A Capture Continuous Capture mAb Polishing Continuous Polishing Step Insulin Purification Continuous Insulin SEC Buffer Exchange Continuous Desalting Biosimilar Manufacturing Biosimilar Continuous Downstream |
| By Scale | Commercial Manufacturing GMP Commercial Continuous Chrom Clinical Manufacturing GMP Clinical Continuous Chrom Process Development Bench-Scale Continuous Chrom |
| By End User | Biopharmaceutical Manufacturers Commercial mAb Continuous CDMOs CDMO Continuous Downstream Biosimilar Manufacturers Biosimilar Continuous Process |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Continuous Chromatography Market trajectory over the forecast period:
BioSMB Multi-Column Continuous Chromatography Technology Is Enabling Higher Resin Utilisation and Smaller Column Footprints in Commercial mAb Manufacturing.Biopharmaceutical downstream processing engineers at commercial monoclonal antibody manufacturing facilities are implementing BioSMB multi-column continuous chromatography systems that maintain the Protein A resin at close to maximum capacity at all times. Through coordinated column loading, washing, and elution cycles. Cytiva continued commercial development and customer implementation of BioSMB continuous Protein A capture systems at commercial mAb manufacturing sites in 2024. This grows biopharmaceutical manufacturer adoption as continuous capture reduces resin requirements and column footprint relative to conventional batch capture.
Periodic Counter-Current Capture Technology Is Enabling Continuous Protein A Capture Without the Full Multi-Column System Complexity of BioSMB.Biopharmaceutical process development scientists evaluating options for semi-continuous mAb capture are adopting periodic counter-current chromatography as a two or three-column sequential loading approach that improves resin utilisation. Reduces residence time compared with single-column batch capture without requiring full SMB hardware investment. Novatek International and Repligen continued development and commercial expansion of PCC chromatography systems for mAb and recombinant protein continuous capture in 2024. This provides biopharmaceutical manufacturers with semi-continuous capture options as steps toward full end-to-end continuous manufacturing.
Integrated Continuous Bioprocessing Technology Is Enabling End-to-End Connection from Bioreactor Harvest to Final Formulation Product.Biopharmaceutical manufacturing scientists designing advanced facility concepts are evaluating integrated continuous bioprocessing systems that connect perfusion bioreactor harvest directly to continuous capture chromatography. Continuous polishing steps in a single connected manufacturing train without intermediate hold tanks. Cytiva, Pall Life Sciences, and multiple academic continuous bioprocessing groups continued development of integrated continuous bioprocessing demonstration systems in 2024, advancing feasibility evidence for end-to-end continuous antibody manufacturing from bioreactor seed to final filtered product.
For related market intelligence, see the Affinity Chromatography Market.
8. Segmental Analysis
By technology, multi-column continuous capture dominated the Continuous Chromatography Market in 2025, driven by growing commercial mAb manufacturer adoption of BioSMB and similar systems achieving higher resin utilisation and smaller column footprints. Biopharmaceutical downstream processing scientists continue adopting multi-column continuous capture as the primary continuous chromatography technology as resin utilisation improvement and column size reduction provide measurable capital and operating cost benefits. Integrated continuous bioprocessing platforms are the fastest-growing technology type, driven by growing biopharmaceutical industry interest in end-to-end connected continuous manufacturing from bioreactor to formulated drug substance. Biopharmaceutical manufacturing engineers are increasing integrated continuous bioprocessing system evaluation as demonstration systems validate end-to-end continuous antibody manufacturing feasibility from bioreactor seed to final filtered product.
By application, mAb capture dominated the Continuous Chromatography Market in 2025, driven by the primary commercial focus of continuous Protein A capture technology on the large monoclonal antibody commercial manufacturing sector. Biopharmaceutical downstream processing engineers continue generating the highest continuous chromatography demand in mAb capture as Protein A resin cost reduction from improved dynamic binding capacity utilisation provides the highest ROI of any continuous chromatography application. Biosimilar manufacturing is the fastest-growing application, driven by the strong cost reduction incentive for biosimilar manufacturers seeking continuous downstream manufacturing as a pathway to lower cost of goods for price-sensitive biosimilar markets. Biosimilar manufacturers are increasing continuous chromatography adoption as continuous Protein A capture resin cost reduction directly improves cost of goods, providing competitive pricing capability in the price-sensitive biosimilar commercial market.
9. Regional Analysis
Regional demand patterns across the Continuous Chromatography Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Continuous Chromatography Market in 2025, with a market share of 45.0%. The region's leadership reflects the technology adoption leadership of major United States biopharmaceutical manufacturers in continuous manufacturing implementation, FDA regulatory engagement with industry on continuous manufacturing guidance development, and the concentration of continuous chromatography technology developers with North American commercial and development headquarters. Large United States biopharmaceutical manufacturers including Genentech, AstraZeneca, and Regeneron are among the earliest commercial adopters of continuous downstream chromatography technologies, generating first commercial continuous Protein A capture implementations and creating reference site evidence for industry adoption. Growing FDA engagement with biopharmaceutical manufacturers on continuous manufacturing regulatory pathway through ICH Q13 implementation is creating a more predictable regulatory submission environment that reduces the perceived regulatory risk of adopting continuous chromatography at commercial manufacturing facilities.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 24.60% during the forecast period. Growing Chinese and South Korean biopharmaceutical manufacturing investment in advanced continuous manufacturing capability, government biosimilar manufacturing programme interest in cost-competitive continuous downstream processing, and expanding biopharmaceutical CDMO sector development across the region are creating demand for continuous chromatography systems. Growing Chinese government investment in advanced biopharmaceutical manufacturing technology and the cost reduction imperative for Chinese biosimilar mAb manufacturers competing on price are creating adoption incentives for continuous Protein A capture at Chinese commercial antibody manufacturing facilities. Growing South Korean and Singaporean biopharmaceutical CDMO sector investment in continuous manufacturing capability to differentiate service offerings is creating demand for continuous chromatography system implementation at Asia Pacific CDMO facilities.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Continuous Chromatography Market was valued at USD 654.82 Mn in 2025 and is projected to reach USD 3,920.55 Mn by 2034, growing at a CAGR of 22.00% over the 2026–2034 forecast period.
The Continuous Chromatography Market is projected to grow at a CAGR of 22.00% from 2026 to 2034.
North America dominated the Continuous Chromatography Market in 2025, with a market share of 45.0%.
The leading companies in the Continuous Chromatography Market include Cytiva (BioSMB), Repligen, Novatek International, GEA Group, ChromaCon, Pall Life Sciences, MCSGP Technology, EMD Millipore (Merck), Semba Biosciences, Asahi Kasei.
Biosmb multi-column continuous chromatography technology is enabling higher resin utilisation and smaller column footprints in commercial mab manufacturing.
By technology, multi-column continuous capture dominated the Continuous Chromatography Market in 2025, driven by growing commercial mAb manufacturer adoption of BioSMB and similar systems achieving higher resin utilisation and smaller column footprints.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.